Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.40% | -15.43% | -9.29% | 7.48% | -34.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.21% | -7.15% | -17.61% | 1.09% | 173.77% |
| Operating Income | 65.21% | 7.15% | 17.61% | -1.09% | -173.77% |
| Income Before Tax | 10.11% | -139.15% | 152.19% | 32.45% | -79.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.59% | -139.58% | 153.69% | 37.88% | -82.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.59% | -139.58% | 153.69% | 37.88% | -82.15% |
| EBIT | 65.21% | 7.15% | 17.61% | -1.09% | -173.77% |
| EBITDA | 65.29% | 7.09% | 17.67% | -0.38% | -174.71% |
| EPS Basic | 99.71% | -- | -- | -- | -- |
| Normalized Basic EPS | 99.79% | -- | -- | -- | -- |
| EPS Diluted | 99.71% | -- | -- | -- | -- |
| Normalized Diluted EPS | 99.79% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 42,311.30% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 42,311.30% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |